Navigation Links
Agendia Wins 2011 Scrip Award for "Best Partnership Alliance"
Date:2/29/2012

IRVINE, Calif. and AMSTERDAM, Feb. 29, 2012 /PRNewswire/ -- Agendia, an innovative molecular cancer diagnostics company, today announced that the company is a recipient of the 2011 Scrip Award for "Best Partnership" for its cooperative alliance between Agendia, AstraZeneca and the Netherlands Cancer Institute (NKI). This is the seventh annual competition to recognize and honor achievements throughout the pharmaceutical industry.

The collaboration between Agendia, AstraZeneca and NKI represents a new approach to personalized diagnostics with the goal of accelerating the delivery of promising personalized therapies to patients by segmenting colorectal cancer at the molecular level.

"This is a model of how bio/pharma and academia can work in new paradigms involving a biotech, a pharma and a major academic research center," panel judges on behalf of Scrip said of the partnership. "This has the potential to pioneer new understanding of colorectal cancer and result in new diagnostics to understand a personalized approach to the treatment of this disease that does not now exist."

Scrip, the leading source for global pharmaceutical industry news, gathers highly respected and independent experts from throughout the pharmaceutical industry to recognize innovations across the field including research, clinical trials and breakthrough drugs. The Best Partnership Alliance award acknowledges the importance of partnerships involving pharmaceutical and biotech companies in developing novel therapeutics.

"This award recognizes the unique alliance that brings together high-level academic research as well as companies known for the successful development of molecular diagnostics and targeted therapies," said David Macdonald, Agendia's CEO. "A key feature of this collaboration is that personalized medicine can be developed much more quickly by combining the different expertise of each of the three individual partners from the beginning. The collabo
'/>"/>

SOURCE Agendia
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Agendia Introduces the SYMPHONY™ Breast Cancer Profile With Paraffin Embedded Tissue
2. Agendia Appoints New CEO and Supervisory Board Member
3. Agendia Receives €1.27 Million in Funding from the EUs Seventh Framework Programme
4. Agendia Inaugurates New State-of-the-Art Genomics Laboratory in Irvine
5. Agendia to Provide Testimony at Public Meeting on FDA Oversight of Laboratory-Developed Tests
6. Agendia to Play Pivotal Role in ISPY-2 Trial for Breast Cancer
7. FDA Broadens Clearance for Agendias MammaPrint(R)
8. /C O R R E C T I O N -- Agendia B.V./
9. Agendias Breast Cancer Recurrence Test MammaPrint Included in International St. Gallen Expert Consensus Recommendations
10. Agendias Breast Cancer Test MammaPrint(R) Identifies New Subset of Low Risk HER2+ Patients
11. Agendias MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Mass. , July 31, 2014  Decision Resources ... technology market intelligence product Marketrack to now include ChinaTrack; ... device landscape in an interactive dashboard providing detailed ... procedure volumes at a hospital level. Other ... , Updated data feed: In addition to end-user surveys ...
(Date:7/31/2014)... July 31, 2014 Lazarus Effect, a medical ... devices to facilitate removal of blood clots, announced the ... financing will support EU commercialization of several approved Lazarus ... Lazarus ReCover™ and Lazarus Cover™ in the ... investor confidence in the value of our novel, platform ...
(Date:7/31/2014)... 31, 2014 Catylix, Inc. ( ... Milpitas, California ) announced today the ... commercialize new fluorination products and related chemistry. ... from the use of substituents that are chemically ... polarity to improve binding and bioavailability. Fluorinated functional ...
Breaking Medicine Technology:Decision Resources Group Announces First Medical Device Account Targeting Tool in China 2Lazarus Effect Closes $5 Million Financing 2Catylix, Inc. and Aspira Scientific Announce Joint Venture to Commercialize New Fluorination Technologies 2
... WOONSOCKET, R.I. , Jan. 12 CVS Caremark Corporation (NYSE: ... increase in its quarterly dividend of approximately 15%, to 8.75 cents ... 2010 to holders of record on January 22, 2010 . This ... up 4.5 cents per share from the previous rate of ...
... , , BETHESDA, Md. , ... in biotechnology for diabetes therapy, and a provider of technical ... companies, today announced the completion of patient enrollment in its ... the safety and efficacy of D-tagatose as an oral treatment ...
Cached Medicine Technology:CVS Caremark Corporation Increases Quarterly Dividend 15% 2Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes 2Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes 3Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes 4Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes 5
(Date:7/31/2014)... 2014 The team at Advanced ... NJ, is proud to announce that they are ... PMR proudly offers many services, including Physical Therapy, ... medical supplies. Some of their physical therapy services ... geriatric therapy among a vast list of others. ...
(Date:7/31/2014)... In a front-page story, the Wall ... & Johnson, is withdrawing its laparoscopic power morcellator due ... This important story has also been reported by ... AP (7/30), the Pittsburgh Business Times (7/30) and TIME ... uterine procedures to, “slice up common uterine masses called ...
(Date:7/31/2014)... , Rest assured, there is a happy ending, ... shows that many college students are stressed out and ... there are simple ways for students to relieve stress ... of UC,s Health Promotion and Education Program. The trouble ... a whole array of different stress-management techniques college students ...
(Date:7/31/2014)... The Never Give Up 26 Foundation looks forward to seeing ... Simply bring your ticket and Mention Never Give Up 26 ... and family. , Packy had unique internal drives, ... optimism continues to impact the lives of many. Overcoming ... a happy life was truly a testament to his character. ...
(Date:7/31/2014)... The “Nucleic Acid Isolation and Purification ... bead based), Consumables & Instruments, by Application (Plasmid ... users - Global Forecasts to 2018” provides a ... opportunities, current market trends, and strategies impacting the ... with the estimates and forecasts of the revenue ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs' Approved, Advanced Physical Medicine and Rehabilitation Now Offering Chiropractic & Podiatric Services 2Health News:Have You Had a Hysterectomy or Removal of Uterine Fibroids? Morcellator Device Withdrawn From Market Due To Cancer Risk 2Health News:Have You Had a Hysterectomy or Removal of Uterine Fibroids? Morcellator Device Withdrawn From Market Due To Cancer Risk 3Health News:Simple tips to fend off freak-outs 2Health News:Simple tips to fend off freak-outs 3Health News:Don't Forget To Mention Never Give Up 26 Foundation 2Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 4
... that has been commissioned by the Australian government states that ... cost effective option to control// the growing epidemic of childhood ... found the various programs based in schools were cost-effective, but ... that many ministers for state who are in favour of ...
... Canada can differ according to provinces, says a new study ... ,People on dialysis in Alberta were four times more ... the study conducted over a five-year period found. Saskatchewan, Atlantic ... for kidneys than Ontario. ,"We can say that ...
... The National Institute of Virology in Pune declared Tuesday there ... 250 km from here in south Gujarat.// ,Additional ... samples from Surat city, and not even a single sample ... NIV, have not yet clarified why two persons had died ...
... August 26 issue of "The Lancet" has revealed that ... past decade// in many countries of the world, especially ... University of Auckland, New Zealand, and colleagues repeated the ... between 2002-2003 to assess the global prevalence of asthma, ...
... a Christchurch General Practitioner for allegedly manipulating a sexual ... account, the GP even bought her lingerie and advised ... ,The doctor has been slapped with a charge ... with the woman in question. Allegedly, the former ...
... Board has indicated that the Klein Government is all set ... early stage breast cancer.// The spokeswoman of the board, Lee ... trials in the United Kingdom before advising the $40,000-per-patient drug ... is available to those patients who are in dire need ...
Cached Medicine News:Health News:Health Experts In Australia Toy With The Idea Of Surgery for Controlling Obesity In Teenagers 2Health News:Rise In Childhood Allergies 2
7 mm curved blade. Round handle....
7 mm strong curved blade. Round handle....
3 mm diameter roller blade, 15 mm from angle to tip. Round handle....
No. 4. 0.75 mm wide x 5 mm long, lightly curved tip, offset to the left. Hexagonal handle....
Medicine Products: